Aptargroup, Inc.
APTARGROUP, INC. is classified under Healthcare / Pharmaceuticals and appears profitable on the latest normalized snapshot.
Business. APTARGROUP, INC. is classified under Healthcare / Pharmaceuticals and appears profitable on the latest normalized snapshot.
Analyst recommendations
8 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressLisa McClain — AptarGroup, Inc. Common Stock2025-06-24 · Republican · MI · Purchase · $1,001 - $15,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
APTARGROUP, INC. is classified under Healthcare / Pharmaceuticals and appears profitable on the latest normalized snapshot.
APTARGROUP, INC. (ATR) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.81 (rule-based classification). Capital structure on the latest snapshot: total assets 5,133,214,000 USD, total equity 2,628,293,000, short-term debt 217,540,000, long-term debt 1,118,415,000. Net cash position is approximately -1,138,689,000 USD. Self-calculated market cap is 7,977,854,720 USD (market_price × shares_outstanding_diluted). Profitability profile: revenue 2,009,376,000, gross profit 0, operating income 234,218,000, net income 160,247,000. Return on equity ~14.9%. Return on assets ~7.6%. Operating-cash-flow to net-income ratio is 1.45. Risk profile from automated assessment: liquidity risk medium, dilution risk medium. Flags: Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk.. Recent news context: [TRIGGER] allocator_boost: allocator_boost (allocator) on ATR — watcher=allocator; producer_version=ws49-p2a-v2; plan_date=2026-08-01; rank=2; ev=8.671845; company_id=4237f50e-7a22-4cf8-822e-0c1432a29168; jurisdiction=MH; term_contributions={'event_proximity': 4.467152, 'gradability': 0.0, 'staleness': 4.204693, 'credibility_interest': 0.0}; days_since_analysis=66; pending_promises=0; reason=Allocator coverage boost rank #2 EV=8.671845 for ATR (hot+stale; days_since=66); contributing_watchers=allocator (source=allocator; url=allocator:2026-08-01:ATR). Additional context: allocator_boost: watcher=allocator; producer_version=ws49-p2a-v2; plan_date=2026-08-01; rank=2; ev=8.671845; company_id=4237f50e-7a22-4cf8-822e-0c1432a29168; jurisdiction=MH; term_contributions={'event_proximity': 4.467152, 'gradability': 0.0, 'staleness': 4.204693, 'credibility_interest': 0.0}; days_since_analysis=66; pending_promises=0; reason=Allocator coverage boost rank #2 EV=8.671845 for ATR (hot+stale; days_since=66); contributing_watchers=allocator.
- Observed GAAP P/E is about 20.31x.
- Return on equity is about 14.9%.
- Debt to equity is about 0.51x.
- [TRIGGER] allocator_boost: allocator_boost (allocator) on ATR — watcher=allocator; producer_version=ws49-p2a-v2; plan_date=2026-08-01; rank=2; ev=8.671845; company_id=4237f50e-7a22-4cf8-822e-0c1432a29168; jurisdiction=MH; term_contributions={'event_proximity': 4.467152, 'gradability': 0.0, 'staleness': 4.204693, 'credibility_interest': 0.0}; days_since_analysis=66; pending_promises=0; reason=Allocator coverage boost rank #2 EV=8.671845 for ATR (hot+stale; days_since=66); contributing_watchers=allocator (source=allocator; url=allocator:2026-08-01:ATR)
- Companyfacts coverage was partial; recent filing facts backfilled property_and_equipment.
- CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) In thousands, brackets denote cash outflows Six Months Ended June 30, 2026 2025 Cash Flows from Operating Activities: Net income $ 160,777 $ 190,395 Adjustments to reconcile net income to net cash provided by operations: Depreciation 132,792 113,720 Amortization 22,574 21,831 Stock-based compensation 24,072 27,208 Provision for CECL 491 769 Loss (gain) on disposition of fixed assets 776 ( 366 ) Net loss (gain) on remeasurement of equity securities 149 ( 1,006 ) Deferred income taxes ( 3,098 ) ( 21,322 ) Defined benefit plan expense 6,885 6,720 Equity in results of affiliates ( 2,118 ) ( 4,395 ) Impairment loss 1,550 — Changes in balance sheet items, excluding effects from foreign currency adjustments: Accounts and other receivables ( 99,336 ) ( 83,207 ) Inventories ( 48,178 ) ( 15,951 ) Prepaid and other current assets ( 18,940 ) ( 21,141 ) Accounts payable, accrued and other liabilities 67,020 21,653 Income taxes payable ( 5,761 ) ( 908 ) Retirement and deferred compensation plan liabilities 64 ( 10,579 ) Retirement and deferred compensation plan assets ( 13,340 ) ( 7,537 ) Other changes, net ( 4,199 ) ( 7,184 ) Net Cash Provided by Operations 222,180 208,700 Cash Flows from Investing Activities: Capital expenditures ( 122,959 ) ( 120,287 ) Proceeds from government grants — 3,308 Proceeds from sale of property, plant and equipment 2,635 79 (Purchases) and maturities of short-term investments, net ( 108 ) 2,819 Acquisition of businesses, net of cash acquired and release of escrow ( 156 ) ( 7,934 ) Acquisition of intangible assets, net ( 893 ) ( 4,006 ) Notes receivable, net ( 406 ) ( 49 ) Net Cash Used by Investing Activities ( 121,887 ) ( 126,070 ) Cash Flows from Financing Activities: Proceeds from notes payable and overdrafts 8,052 — Repayments of notes payable and overdrafts ( 8,820 ) — Proceeds of short-term revolving credit facility, net 37,500 69,103 Proceeds from long-term obligations 6,063 885 Repayments of long-term obligations ( 155,942 ) ( 32,950 ) Payment of contingent consideration obligation ( 3,730 ) — Dividends paid ( 61,531 ) ( 59,641 ) Proceeds from stock option exercises 18,981 10,561 Purchase of treasury stock ( 149,973 ) ( 150,000 ) Redeemable noncontrolling interest 1,112 — Net Cash Used by Financing Activities ( 308,288 ) ( 162,042 ) Effect of Exchange Rate Changes on Cash ( 4,027 ) 17,296 Net Decrease in Cash and Equivalents and Restricted Cash ( 212,022 ) ( 62,116 ) Cash and Equivalents and Restricted Cash at Beginning of Period 404,849 223,844 Cash and Equivalents and Restricted Cash at End of Period $ 192,827 $ 161,728 See accompanying unaudited Notes to Condensed Consolidated Financial Statements.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue $2.01B; Operating income $234.2M.
- ▍Revenue $2.01B
- ▍Operating income $234.2M
- ▍Net margin 8.0%
Revenue $982.9M; Operating income $107.5M.
- ▍Revenue $982.9M
- ▍Operating income $107.5M
- ▍Net margin 7.4%
Revenue $3.78B; Operating income $501.0M.
- ▍Revenue $3.78B
- ▍Operating income $501.0M
- ▍Net margin 10.4%
Revenue $3.58B; Operating income $496.5M.
- ▍Revenue $3.58B
- ▍Operating income $496.5M
- ▍Net margin 10.5%
Revenue $3.58B; Operating income $496.5M.
- ▍Revenue $3.58B
- ▍Operating income $496.5M
- ▍Net margin 10.5%
Revenue $3.49B; Operating income $404.0M.
- ▍Revenue $3.49B
- ▍Operating income $404.0M
- ▍Net margin 8.2%
Revenue $3.49B; Operating income $404.0M.
- ▍Revenue $3.49B
- ▍Operating income $404.0M
- ▍Net margin 8.2%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
- Source documents mention dilution or offering risk.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- EVP and Chief Legal Officer · Stock Option → Common StockDisposed 842 @ $111,38exercise · 2026-05-07
Actions
Ask Handelsavisen
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
- APTARGROUP, INC. company facts · 2026-08-01
- APTARGROUP, INC. 10-Q 2026-07-31 · 2026-08-01
- APTARGROUP, INC. 10-Q 2026-05-01 · 2026-08-01
- APTARGROUP, INC. 10-K 2026-02-06 · 2026-08-01
- APTARGROUP, INC. 10-Q 2025-10-31 · 2026-08-01
- allocator_boost (allocator) on ATR · 2026-08-01
- Aptargroup Inc Market data — analyst estimates · 2026-08-01
- Aptargroup Inc Market data — ESG · 2026-08-01
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,20 %$305M
- Investment Managers · as of 2026-03-310,07 %$154M
- Institutional Investor · as of 2022-09-300,07 %$0M
- Investment Managers · as of 2026-03-310,05 %$68M
- Investment Managers · as of 2026-03-310,04 %$190M
- Investment Managers · as of 2026-03-310,03 %$425M
- Investment Managers · as of 2024-06-300,02 %$867M
- Investment Managers · as of 2026-03-310,02 %$135M
- Investment Managers · as of 2026-03-310,01 %$214M
- Investment Managers · as of 2025-12-310,01 %$844M
- Investment Managers · as of 2026-03-310,01 %$351M
- Institutional Investor · as of 2026-03-310,01 %$64M
- Investment Managers · as of 2026-03-310,01 %$18M
- Brokerage Firms · as of 2026-03-310,01 %$31M
- Institutional Investor · as of 2026-03-310,01 %$19M
- Investment Managers · as of 2026-03-310,01 %$59M
- Institutional Investor · as of 2026-03-310,01 %$130M
- Institutional Investor · as of 2026-03-310,01 %$28M
- Investment Managers · as of 2024-12-310,01 %$23M
- Funds · as of 2026-03-310,00 %$22M
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$24M
- Brokerage Firms · as of 2026-03-310,00 %$14M
- Investment Managers · as of 2026-03-310,00 %$4M
- Institutional Investor · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$11M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
Insider activity
- Segment President · Common StockSold 8 854 @ $135,00$1,2M · 2026-08-03
- Director · Common StockOther 151 · 2026-07-16
- Director · Common StockOther 151 · 2026-07-16
- Director · Common StockOther 151 · 2026-07-16
- Director · Common StockOther 151 · 2026-07-16
- Director · Common StockOther 151 · 2026-07-16
- Director · Common StockOther 151 · 2026-07-16
- Director · Common StockOther 226 · 2026-07-16
- Director · Common StockOther 151 · 2026-07-16
- Director · Common StockOther 151 · 2026-07-16
- CAO · Common StockOther 2 664 · 2026-06-15
- Segment President · Common StockSold 447 @ $116,08$52K · 2026-06-09
- Segment President · Common StockSold 4 553 @ $115,53$526K · 2026-06-09
- Chief Human Resources Officer · Common StockSold 213 @ $114,53$24K · 2026-06-04
- Chief Human Resources Officer · Common StockSold 385 @ $113,52$44K · 2026-06-04
- Chief Human Resources Officer · Common StockSold 2 957 @ $112,36$332K · 2026-06-04
- President, Asia · Common StockSold 4 200 @ $116,13$488K · 2026-05-26
- Segment President · Common StockOther 688 @ $116,50$80K · 2026-05-21
- EVP and Chief Legal Officer · Common StockSold 422 @ $123,38$52K · 2026-05-07
- EVP and Chief Legal Officer · Common StockOther 842 @ $111,38$94K · 2026-05-07
- EVP and Chief Legal Officer · Common StockSold 842 @ $123,45$104K · 2026-05-07
- Director · Common StockOther 1 552 · 2026-05-06
- Director · Common StockOther 1 326 · 2026-05-06
- Director · Common StockOther 1 326 · 2026-05-06
- Director · Common StockOther 1 326 · 2026-05-06
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Return on assets (FY 2025-12-31): 7.5%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 0.9%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 4.9%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 5.7%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 5.4%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 79.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 7.9%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -11.4%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 6.5%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 18.5%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -2.2%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.62xDerived (calculated)
- Return on equity (FY 2025-12-31): 14.7%Derived (calculated)
- Net margin (FY 2025-12-31): 10.4%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 9.4%Derived (calculated)
- EPS (basic) (annual): USD-PER-SHARES 6SEC XBRL filing
- Operating income (annual): USD 501.04MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 6SEC XBRL filing
- Current assets (annual): USD 1.89BSEC XBRL filing
- Total assets (annual): USD 5.25BSEC XBRL filing
- Current liabilities (annual): USD 1.17BSEC XBRL filing
- Cash & equivalents (annual): USD 402.42MSEC XBRL filing
- Pre-tax income (annual): USD 491.38MSEC XBRL filing
- Net income (annual): USD 392.79MSEC XBRL filing